๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liquid chromatographic assay for the non-peptidic protease inhibitor tipranavir in plasma

โœ Scribed by Rolf W. Sparidans; Frits Dost; Kristel M. L. Crommentuyn; Alwin D. R. Huitema; Jan H. M. Schellens; Jos H. Beijnen

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
106 KB
Volume
20
Category
Article
ISSN
0269-3879

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Liquid chromatographic assay for the pro
Liquid chromatographic assay for the protease inhibitor atazanavir in plasma
โœ Rolf W. Sparidans; Frits Dost; Kristel M. L. Crommentuyn; Alwin D. R. Huitema; J ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB

Atazanavir is the most recently introduced protease inhibitor for the suppression of the anti-human immunodeficiency virus. A sensitive and selective reversed-phase liquid chromatographic assay for this drug in human plasma has been developed and validated. Atazanavir was isolated from a 500 microL

High-performance liquid chromatographic
High-performance liquid chromatographic assay for the antiprotozoal agent, tinidazole, in human plasma
โœ K. B. Alton; J. E. Patrick ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 321 KB ๐Ÿ‘ 1 views

A rapid and specific high-performance liquid chromatographic (HPLC) assay for the quantitative determination of tinidazole in human plasma is described. After a simple extraction procedure, the compound is analyzed by HPLC using a reversed-phase column and a UV detector. Quantitation is accomplished